An "eye" in the gut: The appendix as a sentinel sensory organ of the immune intelligence network

Medical Hypotheses

Volumn 63, Issue 4, 2004, Pages 752-758

  Bazar, Kimberly A ^a,c   Lee, Patrick Y ^b   Joon Yun, A ^b  

^a San Mateo County Medical Center   (United States)

^b STANFORD UNIVERSITY   (United States)

^c USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; APPENDICITIS; COGNITIVE DEFECT; DIGESTION; ILEOCECAL VALVE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; NERVE CELL NETWORK; PRIORITY JOURNAL; REVIEW; SENSE ORGAN; SMALL INTESTINE;

CELLULAR ORGANISMS;

EID: 5644253927     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.04.008     Document Type: Article

References (67)

1. Watanobe H., Hayakawa Y. Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology. 144(11):2003;4868-4875
2. Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 84(1):2004;87-136
3. Friedman E.M., Irwin M.R. Modulation of immune cell function by the autonomic nervous system. Pharmacol. Ther. 74(1):1997;27-38
4. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physician. 108(5):1996;374-381
5. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52(4):2000;595-638
6. Panina-Bordignon P., Mazzeo D., Lucia P.D., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100(6):1997;1513-1519
7. Lorton D., Lubahn C., Bellinger D.L. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr. Drug Targets Inflamm. Allergy. 2(1):2003;1-30
8. Buller K.M. Neuroimmune stress responses: reciprocal connections between the hypothalamus and the brainstem. Stress. 6(1):2003;11-17
9. Capuron L., Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 17(Suppl 1):2003;S119-S124
10. Garcia-Garcia F., Yoshida H., Krueger J.M. Interleukin-8 promotes non-rapid eye movement sleep in rabbits and rats. J. Sleep Res. 13(1):2004;55-61
11. Xiong H., Boyle J., Winkelbauer M., et al. Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J. Neurosci. Res. 71(4):2003;600-607
12. Blanas E., Davey G.M., Carbone F.R., Heath W.R. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J. Immunol. 164(6):2000;2890-2896
13. Reyes V.E., Ye G., Ogra P.L., Garofalo R. Antigen presentation of mucosal pathogens: the players and the rules. Int. Arch. Allergy Immunol. 112(2):1997;103-114
14. Mowat A.M., Viney J.L. The anatomical basis of intestinal immunity. Immunol. Rev. 156:1997;145-166
15. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18(7):1997;335-343
16. Keren D.F. Antigen processing in the mucosal immune system. Semin. Immunol. 4(4):1992;217-226
17. Richman L., Graeff A.S., Strober W. Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell. Immunol. 62:1981;110
18. + dendritic cell population in mouse Peyer's patches. Eur. J. Immunol. 26:1996;1801
19. Kelsall B.L., Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J. Exp. Med. 183:1996;237
20. Maric I., Holt P.G., Perdue M.H., Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J. Immunol. 156:1996;1408
21. Liu L.M., MacPherson G.G. Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. Immunology. 85:1995;88
22. Mertz H.R. Overview of functional gastrointestinal disorders: dysfunction of the brain-gut axis. Gastroenterol. Clin. North Am. 32(2):2003;463-476
23. Welch M.G., Keune J.D., Welch-Horan T.B., Anwar N., Anwar M., Ruggiero D.A. Secret inactivates visceral brain regions in the rat including areas abnormal in autism. Cell. Mol. Neurobiol. 23(4-5):2003;817-837
24. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. Rev. 27(8):2004;765-776
25. Pelletier J.G., Pare D. Role of amygdala oscillations in the consolidation of emotional memories. Biol. Psychiatry. 55(6):2004;559-562
26. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA. 92:1995;8734-8738
27. Mazzucchelli C., Pannacci M., Nonno R., Lucini V., Fraschini F., Stankov B.M. The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res. Mol. Brain Res. 39:1996;117-126
28. A receptor function by Mel1a and Mel1b receptors. Nat. Neurosci. 2:1999;401-403
29. El-Sherif Y., Tesoriero J., Hogan M.V., Wieraszko A. Melatonin regulates neuronal plasticity in the hippocampus. J. Neurosci. Res. 72(4):2003;454-460
30. Collins D.R., Davies S.N. Melatonin blocks the induction of long-term potentiation in an. N -methyl-D-aspartate independent manner Brain Res. 767:1997;162-165
31. Hadjiivanova C., Belcheva S., Belcheva I. Cholecystokinin and learning and memory processes. Acta Physiol. Pharmacol. Bulg. 27(2-3):2003;83-88
32. Carlini V.P., Monzon M.E., Varas M.M., et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem. Biophys. Res. Commun. 299(5):2002;739-743
33. Shumyatsky G.P., Tsvetkov E., Malleret G., et al. Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell. 111(6):2002;905-918
34. Howell O.W., Scharfman H.E., Herzog H., Sundstrom L.E., Beck-Sickinger A., Gray W.P. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 86(3):2003;646-659
35. Cadiacio C.L., Milner T.A., Gallagher M., Pierce J.P. Hilar neuropeptide Y interneuron loss in the aged rat hippocampal formation. Exp. Neurol. 183(1):2003;147-158
36. Dutar P., Vaillend C., Viollet C., et al. Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice. Neuroscience. 112(2):2002;455-466
37. Zhou C.J., Shioda S., Yada T., Inagaki N., Pleasure S.J., Kikuyama S. PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr. Protein Pept. Sci. 3(4):2002;423-439
38. Funahashi H., Yada T., Suzuki R., Shioda S. Distribution, function, and properties of leptin receptors in the brain. Int. Rev. Cytol. 224:2003;1-27
39. Whittaker E., Vereker E., Lynch M.A. Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus. Brain Res. 827(1-2):1999;229-233
40. 2+ signaling in mouse dentate gyrus. J. Neurophysiol. 88(6):2002;3078-3086
41. Dudai Y. Neurobiology: fear thou not. Nature. 421(6921):2003;325-327
42. Balschun D., Reymann K.G. Cholecystokinin (CCK-8S) prolongs 'unsaturated' theta-pulse induced long-term potentiation in rat hippocampal CA1 in vitro. Neuropeptides. 26(6):1994;421-427
43. Roberto M., Scuri R., Brunelli M. Differential effects of PACAP-38 on synaptic responses in rat hippocampal CA1 region. Learn. Mem. 8(5):2001;265-271
44. Li S., Aou X.L., Oomura Y., Hori N., Fukunaga K., Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 113(3):2002;607-615
45. Tando Y., Algul H., Schneider G., Weber C.K., Weidenbach H., Adler G., et al. Induction of IkappaB-kinase by cholecystokinin is mediated by trypsinogen activation in rat pancreatic lobules. Digestion. 66(4):2002;237-245
46. Nelson R.J. Seasonal immune function and sickness response. Trends Immunol. 25(4):2004;184-192
47. Roberts J.E. Light and immunomodulation. Ann. N. Y. Acad. Sci. 917:2000;435-445
48. Torii H., Tamaki K., Granstein R.D. The effect of neuropeptides/hormones on Langerhans cells. J. Dermatol. Sci. 20(1):1998;21-28
49. Ganea D., Rodriguez R., Delgado M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Cell. Mol. Biol. 49(2):2003;127-142
50. Zukowska Z., Pons J., Lee E.W., Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can. J. Physiol. Pharmacol. 81(2):2003;89-94
51. Waelput W., Brouckaert P., Broekaert D., Tavernier J. A role for leptin in the systemic inflammatory response syndrome (SIRS) and in immune response. Curr. Drug. Targets Inflamm. Allergy. 1(3):2002;277-289
52. Broglio F., Gottero C., Arvat E., Ghigo E. Endocrine and non-endocrine actions of ghrelin. Horm. Res. 59(3):2003;109-117
53. Paran D., Paran H. Somatostatin analogs in rheumatoid arthritis and other inflammatory and immune-mediated conditions. Curr. Opin. Investig. Drugs. 4(5):2003;578-582
54. Delgado M., Abad C., Martinez C., Juarranz M.G., Leceta J., Ganea D., et al. PACAP in immunity and inflammation. Ann. N. Y. Acad. Sci. 992:2003;141-157
55. Kilhamn J., Lundin S.B., Brevinge H., Svennerholm A.M., Jertborn M. Y-and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine. Clin. Diagn. Lab. Immunol. 10(3):2003;426-430
56. Bauer W.M., Litchtin A., Lashner B.A. Can colectomy cure immune thrombocytopenic purpura in a patient with ulcerative colitis? Dig Dis. Sci. 44(11):1999;2330-2333
57. Kathula S.K., Polenakovik H., el-Tarabily M., Polenakovik S. Complete resolution of refractory immune thrombocytopenic purpura after colectomy for ulcerative colitis. Int. J. Clin. Pract. 55(9):2001;647-648
58. Benbow C.P. Physiological correlates of extreme intellectual precocity. Neuropsychologia. 24(5):1986;719-725
59. Gutstadt L.B., Gillette J.W., Mrazek D.A., Fukuhara J.T., LaBrecque J.F., Strunk R.C. Determinants of school performance in children with chronic asthma. Am. J. Dis. Child. 143(4):1989;471-475
60. Gibson P.G., Henry R.L., Shah S., Powell H., Wang H. Migration to a western country increases asthma symptoms but not eosinophilic airway inflammation. Pediatr. Pulmonol. 36(3):2003;209-215
61. Ross G., Sammaritano L., Nass R., Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch. Pediatr. Adolesc. Med. 157(4):2003;397-402
62. Crawford S.G., Kaplan B.J., Kinsbourne M. The effects of parental immunoreactivity on pregnancy, birth, and cognitive development: maternal immune attack on the fetus? Cortex. 28(3):1992;483-491
63. Benasich A.A. Impaired processing of brief, rapidly presented auditory cues in infants with a family history of autoimmune disorder. Dev. Neuropsychol. 22(1):2002;351-372
64. Temple C.M. Academic discipline, handedness and immune disorders. Neuropsychologia. 28(3):1990;303-308
65. Sakic B., Szechtman H., Denburg S., Carbotte R., Denburg J.A. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 54(1):1993;57-66
66. Hassler M., Gupta D. Functional brain organization, handedness, and immune vulnerability in musicians and non-musicians. Neuropsychologia. 31(7):1993;655-660
67. Check E. Link from hygiene to allergies gains support. Nature. 428(6981):2004;354